124 related articles for article (PubMed ID: 33559792)
1. Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.
Jochumsen MR; Sörensen J; Tolbod LP; Pedersen BG; Frøkiær J; Borre M; Bouchelouche K
EJNMMI Res; 2021 Feb; 11(1):12. PubMed ID: 33559792
[TBL] [Abstract][Full Text] [Related]
2. Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na
Jochumsen MR; Sörensen J; Pedersen BG; Nyengaard JR; Krag SRP; Frøkiær J; Borre M; Bouchelouche K; Tolbod LP
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):532-542. PubMed ID: 32808078
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. The additional value of
Heetman JG; Paulino Pereira LJ; Kelder JC; Soeterik TFW; Wever L; Lavalaye J; van der Hoeven EJRJ; Lam MGEH; van Melick HHE; van den Bergh RCN
Prostate; 2024 May; ():. PubMed ID: 38704755
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of integrated
Zeng Y; Leng X; Liao H; Jiang G; Chen P
Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
[TBL] [Abstract][Full Text] [Related]
7. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
[TBL] [Abstract][Full Text] [Related]
8. Ability of
Yi N; Wang Y; Zang S; Yang L; Liu H; Sun H; Wang L; Wang F
Cancer Med; 2023 Mar; 12(6):7140-7148. PubMed ID: 36519688
[TBL] [Abstract][Full Text] [Related]
9. Direct Patlak Reconstruction of [
Rasul S; Geist BK; Einspieler H; Fajkovic H; Shariat SF; Schmitl S; Mitterhauser M; Bartosch R; Langsteger W; Baltzer PAT; Beyer T; Ferrara D; Haug AR; Hacker M; Rausch I
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761975
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
[TBL] [Abstract][Full Text] [Related]
11. Detection and localisation of primary prostate cancer using
Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
[TBL] [Abstract][Full Text] [Related]
12. Role of [
Ghezzo S; Mapelli P; Bezzi C; Samanes Gajate AM; Brembilla G; Gotuzzo I; Russo T; Preza E; Cucchiara V; Ahmed N; Neri I; Mongardi S; Freschi M; Briganti A; De Cobelli F; Gianolli L; Scifo P; Picchio M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2548-2560. PubMed ID: 36933074
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous
Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Tumor Perfusion Imaging with
Jochumsen MR; Tolbod LP; Pedersen BG; Nielsen MM; Høyer S; Frøkiær J; Borre M; Bouchelouche K; Sörensen J
J Nucl Med; 2019 Aug; 60(8):1059-1065. PubMed ID: 30683762
[TBL] [Abstract][Full Text] [Related]
15. Lesion-to-background ratio threshold value of SUVmax of simultaneous [
Zhao J; Hamm B; Brenner W; Makowski MR
Insights Imaging; 2020 Dec; 11(1):137. PubMed ID: 33331959
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-PSMA-11 PET/CT combining ADC value of MRI in the diagnosis of naive prostate cancer: Perspective of radiologist.
Wang L; Yu F; Yang L; Zang S; Xue H; Yin X; Guo H; Sun H; Wang F
Medicine (Baltimore); 2020 Sep; 99(36):e20755. PubMed ID: 32898989
[TBL] [Abstract][Full Text] [Related]
17.
Maserumule LC; Mokoala KMG; van de Wiele C; Popoola G; Hlongwa KN; Ndlovu H; Maes A; Vorster M; Sathekge MM
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453632
[TBL] [Abstract][Full Text] [Related]
18. The value of
Hong JJ; Liu BL; Wang ZQ; Tang K; Ji XW; Yin WW; Lin J; Zheng XW
EJNMMI Res; 2020 Nov; 10(1):138. PubMed ID: 33169183
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Analysis on [
Feliciani G; Celli M; Ferroni F; Menghi E; Azzali I; Caroli P; Matteucci F; Barone D; Paganelli G; Sarnelli A
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454793
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of tumor blood flow quantification with
Jochumsen MR; Bouchelouche K; Nielsen KB; Frøkiær J; Borre M; Sörensen J; Tolbod LP
EJNMMI Res; 2019 Jul; 9(1):58. PubMed ID: 31273483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
